Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plecanatide in Chronic Idiopathic Constipation (CIC3)
NCT01982240Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Nov 2013
- Primary completion
- Apr 2015
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of plecanatide in chronic idiopathic constipation (CIC), sponsored by Valeant Pharmaceuticals. Started Nov 2013; status: completed.
02
Drugs
plecanatide
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT01982240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01982240.